Selumetinib in Children with Inoperable Plexiform Neurofibromas is a research paper published in New England Journal of Medicine (2020). On theSindex it has a DataRank of 9.0. It has been cited 708 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.985
From this paper's citation signal
Citation Network Contribution
8.0
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
Developmental and Hyperactive Ras Tumor (DHART) Spore
Grant: U54 CA196519-04
NCI NIH HHS
Grant: U54 CA196519
Intramural NIH HHS
Grant: Z99 CA999999
Neurofibromatosis Therapeutics Acceleration Program
AstraZeneca
National Cancer Institute Intramural Research Program
FWCI
31.14
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals